Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FAM20B |
| Upstream (Parents) |
|---|
| (<<) LOC652694///IGKV1-5///IGKC → FAM20B |
| (<<) LOC100130100///LOC652694///LOC652493///LOC650405///IGKV1-5///IGKC → FAM20B |
| Downstream (Children) |
|---|
| FAM20B → IGL@ (>>) |
| FAM20B → IGLV2-11///IGLV2-18///IGLV2-23 (>>) |
| FAM20B → TNFRSF17 (>>) |
| FAM20B → IGLV3-19 (>>) |
| FAM20B → IGHV4-31///IGHV@///IGHM///IGHG1///IGHA1 (>>) |
| FAM20B → C12orf32///IGHG1 (>>) |
| FAM20B → IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA1 (>>) |
| FAM20B → IGLV2-18///IGLV3-19///IGL@ (>>) |
| FAM20B → RHAG (>>) |
| FAM20B → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHM///IGHG1///IGHA2///IGHA1///IGH@ (>>) |
| FAM20B → LAX1 (>>) |
| FAM20B → IGLV6-57 (>>) |
| FAM20B → CD79A (>>) |
| FAM20B → LOC100134331///LOC100126583///LOC652128///IGHG1///IGHD///IGH@ (>>) |
